Efficacy, tolerability and remission: a 15 year switching study of oral antipsychotics from typical to atypical and back

被引：1
|
作者：
Franza, F. [1 ]
Dinelli, G. [2 ]
Fiorentino, N. [1 ]
di Celso, R. Mazziotti [1 ]
Dinelli, E. [2 ]
Soddu, A. [1 ]
Fasano, V. [1 ]
Battista, A. [1 ]
机构：
[1] Casa Cura Villa Pini, Dept Psychiat, Avellino, Italy
[2] Casa Cura Pk Villa Napoleon, Dept Psychiat, Preganziol, TV, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70485-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [31] Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study
    Alptekin, Koksal
    Hafez, Jamal
    Brook, Shlomo
    Akkaya, Cengiz
    Tzebelikos, Errikos
    Ucok, Alp
    El Tallawy, Hamdy
    Danaci, Aysen-Esen
    Lowe, Wing
    Karayal, Onur N.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2009, 24 (05) : 229 - 238
  • [32] Benefits of switching from typical to atypical antipsychotic medications: A longitudinal study in a community-based setting
    Cook, PE
    Goldberg, JO
    Van Lieshout, RJ
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (09): : 870 - 874
  • [33] Effectiveness and tolerability of long-acting risperidone: A 9-month open-label extension of a 12-week switching study from oral antipsychotics
    Kim, Chang Yoon
    Chung, Seockhoon
    Hahm, Bong-Jin
    Hong, Kyung Sue
    Yoon, Jin-Sang
    Kim, Young-Hoon
    Bahk, Won-Myong
    Lee, Sang-Yeol
    Lee, Yanghyun
    Chung, In-Won
    Kim, Chan-Hyung
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 (03) : 192 - 198
  • [34] Efficacy and tolerability study of flexibly dosed paliperidone ER in ASEAN schizophrenia patient who previously unsuccessfully treated with other oral antipsychotics
    Thavichachart, N.
    Conde, B.
    Sobrevega, E.
    Chung, W. S.
    Eu, P. W.
    Sulaiman, A. H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 243 - 243
  • [35] Switching therapy from conventional and atypical antipsychotics to ziprasidone in outpatients with schizophrenia: an 8 week, open-label study
    Rossi, A.
    Vita, A.
    Sciarretta, A.
    Romeo, F.
    Tiradritti, P.
    Rappard, F.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 457 - 458
  • [36] Switching to quetiapine from other atypical antipsychotics improves sexual dysfunction: Preliminary results of an open-label study
    Bouchard, RH
    Demers, MF
    Roy, MA
    Almeras, N
    Villeneuve, J
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 180 - 180
  • [37] Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: The mobile study
    Cooper, C
    Delmas, PD
    Felsenberg, D
    Hughes, C
    Mairon, N
    Bonvoisin, B
    Reginster, JY
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 68 - 68
  • [38] Stroke Risk Among Elderly Users of Haloperidol and Typical Antipsychotics Versus Atypical Antipsychotics: A Real-World Study From a US Health Insurance Claims Database
    Fife, Daniel
    Blacketer, Clair
    Knight, R. Karl
    Weaver, James
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (05): : 499 - 510
  • [39] Switching from oral antipsychotics to aripiprazole once-monthly in a naturalistic setting: hospitalisation rates from a mirror study
    Kane, J. M.
    Zhao, C.
    Johnson, B.
    Baker, R. A.
    Eramo, A.
    McQuade, R. D.
    Duca, A.
    Sanchez, R.
    Peters-Strickland, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S549 - S550
  • [40] THE EFFICACY AND SAFETY OF BLONASERIN AFTER SWITCHING FROM OTHER ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS: AN OPEN-LABEL, MULTI-CENTER TRIAL
    Yoon, Bo-Hyun
    Bahk, Won-Myong
    Kwon, Young Joon
    Lee, Sang-Yeol
    Lee, Kwanghun
    Kim, Moon Doo
    Park, Sung-Yong
    Song, Min-Kyu
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S236 - S236
12345